However, it is undeniable that the effect of mir-30d on diabetic cardiomyopathy may be mediated by a variety of mechanisms in addition to the foxo3a–ARC–caspase-1 pathway, and further investigation is required to unveil the other mechanisms involved. This evidence concerns the gene CASP1 and diabetic cardiomyopathy.